South Korea Bioinformatics Services Market Size, Share, and COVID-19 Impact Analysis, By Type (NGS, Chemoinformatics, Microarray Data Analysis, and Biological Data Curation), By Application (Proteomics and Metabolomics), and South Korea Bioinformatics Services Market Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jul 2025
REPORT ID SI14270
PAGES 213
REPORT FORMAT PathSoft

South Korea Bioinformatics Services Market Insights Forecasts to 2035

  • The South Korea Bioinformatics Services Market Size Was Estimated at USD 78.45 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 14.02% from 2025 to 2035
  • The South Korea Bioinformatics Services Market Size is Expected to Reach USD 332.3 Million by 2035

South Korea Bioinformatics Services Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, The South Korea Bioinformatics Services Market Size is anticipated to reach USD 332.3 Million by 2035, growing at a CAGR of 14.02% from 2025 to 2035. To speed up drug research and development, the biotechnology and pharmaceutical sectors are depending more and more on bioinformatics services.

 

Market Overview

The bioinformatics services market involves the application of computational tools and software to analyze biological data, including genomics, proteomics, and metabolomics. These services support drug discovery, disease diagnosis, and personalized medicine. The faster data interpretation, improved research accuracy, and cost-effective solutions for managing large-scale biological datasets. Opportunities are expanding due to rising demand for precision medicine, increasing research in genomics, and technological advances in sequencing and data analytics. Countries like South Korea, include funding for biotech R&D, development of national genomics databases, and support for academic-industry collaborations. These efforts aim to enhance healthcare outcomes, strengthen biotech innovation, and position the country as a leader in life sciences and computational biology.

 

Report Coverage

This research report categorizes the market for South Korea bioinformatics services market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea bioinformatics services market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea bioinformatics services market.

 

South Korea Bioinformatics Services Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 78.45 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :14.02%
2035 Value Projection:USD 332.3 Million
Historical Data for:2020-2023
No. of Pages:213
Tables, Charts & Figures:120
Segments covered:By Type and By Application
Companies covered:: Insilicogen Inc., Bio Design Lab, MyGenomeBox, Seoulin Bioscience, AIMS BioScience, Trial Informatics, BIORCHESTRA, Macrogen Inc., Bioneer Corporation, LabGenomics, and Others
Pitfalls & Challenges:COVID-19 Impact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The growing need to analyse large volumes of biological data generated through genomics, proteomics, and metabolomics research. Rising demand for precision medicine, personalized healthcare, and efficient drug discovery accelerates adoption. Advances in next-generation sequencing (NGS), cloud computing, and AI-based analytics enhance data processing capabilities. Additionally, increased investments in biotechnology and government support for genomic research further boost market growth.

 

Restraining Factors

High development and infrastructure costs limit adoption, managing large-scale genomic, proteomic, and clinical datasets requires substantial investment in software, high-performance computing, and secure storage. Lack of standardized data formats and interoperability frameworks complicates combining datasets across platforms, delaying analysis and lowering confidence in outcomes.

 

Market Segmentation

The South Korea bioinformatics services market share is classified into type, and application.

 

  • The NGS segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea bioinformatics services market is segmented by type into NGS, chemoinformatics, microarray data analysis, and biological data curation. Among these, the NGS segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Its critical role in rapidly generating vast genomic data essential for research, diagnostics, and personalized medicine. Advances in sequencing technologies have made NGS more affordable and accessible, fueling demand in healthcare, agriculture, and biotechnology. Additionally, South Korea’s strong focus on genomics research and government investments in precision medicine and biotech innovation drive growth, positioning NGS as the fastest-growing segment during the forecast period.

 

  • The proteomics segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea bioinformatics services market is segmented by application into proteomics and metabolomics. Among these, the proteomics segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. The increasing demand for understanding protein functions, interactions, and their roles in disease mechanisms. Proteomics supports drug discovery, biomarker identification, and personalized medicine, aligning with South Korea’s growing biotech and pharmaceutical industries. Advanced analytical technologies and government funding for proteomics research further boost adoption.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea bioinformatics services market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Insilicogen Inc.
  • Bio Design Lab
  • MyGenomeBox
  • Seoulin Bioscience
  • AIMS BioScience
  • Trial Informatics
  • BIORCHESTRA
  • Macrogen Inc.
  • Bioneer Corporation
  • LabGenomics
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea bioinformatics services market based on the below-mentioned segments:

 

South Korea Bioinformatics Services Market, By Type

  • NGS
  • Chemoinformatics
  • Microarray Data Analysis
  • Biological Data Curation

 

South Korea Bioinformatics Services Market, By Application

  • Proteomics
  • Metabolomics

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies